During the month of October, END7 student supporters are celebrating NTD Success Stories — spreading the exciting news that many countries around the world have already made incredible progress towards the control and elimination of some NTDs. In recent weeks, there have been many new successes to celebrate.
Dr. Sazaly has been involved with dengue research for over 20 years and has also maintained strong research interest in emerging infectious diseases. His interest in dengue, in particular, is rooted in its knowledge gaps: “it is a fascinating disease needing a lot more research to take on.” In an interview with DVI, Dr. Sazaly shares more on his views of dengue prevention and control and needs in the dengue research field.

The initial research for the Ebola vaccine was published in 2003, where it sat for more than a decade waiting for a vaccine manufacturer to invest in licensing and development. Only after the 2014 outbreak began did the U.S.

In countries around the world, cadres of information specialists work behind the scenes, tracking expenditures and keeping immunization managers informed of financial matters. They play a crucial part in helping to ensure that all people have access to vaccines. In Cameroon, Mr.

by Peter Hotez, M.D., Ph.D. Hotez is Dean of the National School of Tropical Medicine at Baylor College of Medicine where he is also the Texas Children’s Hospital Endowed Chair in Tropical Pediatrics and the University Professor of Biology at Baylor University.

Smallpox was one of the most terrifying diseases in human history. Smallpox plagued humanity for thousands of years, killing one-third of its victims and disfiguring those who survived.

This blog post was originally published on Impatient Optimists, by Pascal Barollier, Director of Communications at Gavi, the Vaccine Alliance.

Pages